Skip to main content
Figure 4 | Critical Care

Figure 4

From: Prognostic value of procalcitonin in respiratory tract infections across clinical settings

Figure 4

Association between time to severe adverse events and admission procalcitonin levels in lower acute respiratory tract infection and community-acquired pneumonia patients. (A) Time to treatment failure is significantly shorter in lower acute respiratory tract infection (ARI) patients with higher procalcitonin (PCT) levels on admission (P <0.0001). (B) Time to death is significantly shorter in lower ARI patients with higher PCT levels on admission (P <0.0001). (C) Time to treatment failure is significantly shorter in patients with community-acquired pneumonia (CAP) with higher PCT levels on admission (P <0.01). (D) Time to death is significantly shorter in patients with CAP with higher PCT levels on admission (P <0.01). ED, Emergency department. Treatment failure is defined as death, ICU admission, rehospitalisation, complications or recurrent or worsening infection within 28 days.

Back to article page